This website is available in:
To change websites, find a country in the A - Z list then choose a language.
To change websites, click on the map pins to find a country then choose a language.
HomeLife SciencesClinical Research ServicesLate Phase II - IVBiomarker Testing
At SGS, we have over 20 years’ experience in biomarker assay development services and analysis and we operate out of two of our own GLP laboratories. With 125 specialized staff, this makes our bioanalytical facility one of the largest in Europe. Pharma and biotech companies of all sizes choose us as their preferred bioanalytical partner because we have the expertise to develop assays de novo – and support large-scale routine sample analysis.
Whether for testing efficacy or safety of drugs in development, our biomarker bioanalytical services cover a range of therapeutic areas to include: